InsiderClue
← All stocks

OMEROS CORP

OMER Mostly scheduled
CIK 0001285819 #2345 in the set updated 17 Sep 2026
Bought (120 mo)
$40.50K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$18.93M
$0.00 on a plan · $18.21M straight out of an exercise
Sold at will
$726.83K
5 of 51 sales
Net
−$18.89M
−$686.33K against sales at will

By person

10 insiders · 69 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Demopulos Gregory A MD
Chairman, CEO & President
$25.20K (1)
$10.39M (13) scheduled
−$10.36M
1,769,308
2.44%
$32.81M
+33.4%
Kelbon Marcia S.
VP Patent and General Counsel
—
$3.36M (7) scheduled
−$3.36M
210,645
0.2910%
$3.91M
+28.8%
JACOBSEN MICHAEL A
VP, Finance & CAO
—
$2.04M (11) scheduled
−$2.04M
14,000
0.0193%
$259.58K
—
Borges David J.
VP, Finance & CAO
—
$1.04M (5) scheduled
−$1.04M
0
0.0000%
$0.00
−100.0%
Cancelmo Peter B
VP, General Counsel
—
$929.67K (2) scheduled
−$929.67K
200
0.0003%
$3.71K
0.0%
Cable Thomas J.
Director
—
$853.16K (9) scheduled
−$853.16K
35,067
0.0484%
$650.20K
−23.9%
HANISH ARNOLD C
Director
—
$314.39K (4) scheduled
−$314.39K
22,400
0.0309%
$415.33K
+80.6%
Demopulos Peter A MD
Director
$15.30K (1)
—
+$15.30K
372,898
0.5151%
$6.91M
+6.7%
Hood Leroy E. MD PhD
Director
—
—
—
74,390
0.1028%
$1.38M
+36.8%
Bumol Thomas F.
Director
—
—
—
10,000
0.0138%
$185.42K
—

Individual transactions

2
Insider
Date
Role
Action
Shares
Price
Amount
Demopulos Gregory A MD
17 Nov 2023
Chairman, CEO & President
Buy indirect
15,000
$1.68
$25.20K
Demopulos Peter A MD
15 Nov 2023
Director
Buy
10,000
$1.53
$15.30K
Show all 69 transactions →

What was left out

Form 4 filings counted 160
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 46
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 3,693,782
Sales filed before the plan box existed 4
History held since 16 Sep 2016